Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy

Expert Opinion on Pharmacotherapy
Philip G Janicak, Jeffrey T Rado

Abstract

Bipolar disorder is characterized by mood instability, which can be challenging to manage. First-line pharmacological approaches usually involve lithium, anticonvulsants and antipsychotics. Over the past fifteen years, several second-generation antipsychotics have demonstrated benefits for various phases of this disorder. This article examines the pharmacodynamics and pharmacokinetics of quetiapine ; its evidence base as an acute and maintenance monotherapy or adjunctive therapy for bipolar manic or mixed episodes is also discussed, along with the related issues of its safety and tolerability. In the context of bipolar disorder, quetiapine is the only agent approved as a monotherapy or adjunct therapy for acute manic/mixed episodes in adults and adolescents; as a monotherapy for acute depressive episodes in adults; and as an adjunctive maintenance therapy for bipolar I and II disorder in adults. In addition to its antipsychotic properties, this broad mood-stabilizing potential may simplify the management of select patients.

References

Oct 5, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Melissa P DelbelloStephen M Strakowski
Jun 14, 2003·Journal of Child and Adolescent Psychopharmacology·Brian McConvilleKerri Browne
Nov 13, 2004·Journal of Clinical Psychopharmacology·Lakshmi N YathamAnd Mårten Vågerö
Sep 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Roger S McIntyreJamie Mullen
Mar 17, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Melissa P DelbelloStephen M Strakowski
Mar 27, 2007·Journal of Affective Disorders·Eduard VietaBjörn Paulsson
Mar 27, 2007·Journal of Affective Disorders·Caleb M AdlerStephen M Strakowski
May 9, 2007·Archives of General Psychiatry·Kathleen R MerikangasRonald C Kessler
Jun 7, 2007·Journal of Affective Disorders·Joseph F GoldbergS Nassir Ghaemi
Mar 18, 2008·Journal of Clinical Psychopharmacology·Keming GaoJoseph R Calabrese
Sep 17, 2008·Journal of Clinical Psychopharmacology·Jens M LangoschHeinz Grunze
Jan 20, 2009·BMC Biotechnology·Patricia A BrownRuxandra Draghia-Akli
Feb 13, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeUNKNOWN WFSBP Task Force On Treatment Guidelines For Bipolar Disorders
May 26, 2011·Expert Opinion on Pharmacotherapy·Philip G Janicak, Jeffrey T Rado
Jul 8, 2011·The International Journal of Neuropsychopharmacology·Eduard VietaBjörn Paulsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here